Veterans continue to die by suicide at unacceptably high rates despite substantial federal investment in mental health and suicide prevention programs. Current VA data and peer-review evidence clearly indicate that broad-based clinical safeguards—rooted in informed consent, comprehensive differential diagnosis, and patient-centered practice standards—are essential to reduce preventable deaths and improve clinical outcomes for veterans.

The Crisis: Veteran Suicide and System Gaps

Veteran suicide remains a persistent public health challenge. The VA conducts the largest national analysis of veteran suicide, revealing sustained suicide incidence that demands systemic action.

Certain demographic groups (e.g., younger veterans, women veterans, and those with medical comorbidities) exhibit elevated risk profiles that require tailored interventions.

 

Current prescribing practices and polypharmacy are associated with elevated risk of suicide and adverse outcomes. Long-term psychoactive medication use and co-prescriptions (e.g., opioids with benzodiazepines) correlate with increased risk of suicide and unintentional overdose death among veteran populations.

Policy Recommendation #1: Mandate Written Informed Consent for High-Risk Medications

Rationale:
Written informed consent is a cornerstone of patient safety and ethical care. In VA practice, formal written consent is required for long-term opioid therapy under VHA Directive 1005, with documented evidence that consent processes reduce high-risk prescribing.

Gap: Current policy does not consistently mandate written consent for many other high-risk drug classes—including benzodiazepines, antipsychotics, stimulants, antidepressants and sedative-hypnotics—despite documented associations with suicide risk and morbidity.

Action: Expand written informed consent requirements across high-risk medication classes commonly prescribed to veterans, ensuring clinicians:

• disclose documented risks and benefits, including suicide-related warnings,
• explain non-pharmacologic alternatives and monitoring plans,
• and obtain comprehensive, documented veteran consent prior to initiating therapy.

Legislative Support: Proposed federal bills such as the Written Informed Consent Act would mandate enhanced consent standards to improve transparency and patient safety.

Policy Recommendation #2: Systematize Comprehensive Differential Diagnosis

Rationale:
Symptom-based care without thorough differential diagnosis contributes to misdiagnosis, overtreatment, and neglect of underlying conditions that contribute to distress, pain, and suicide risk. Peer-reviewed research demonstrates that social determinants, medical comorbidity, and under-recognized factors significantly influence suicide outcomes.

Action: Incorporate standardized differential diagnosis protocols into clinical practice guidelines, including:

• structured assessment tools for traumatic brain injury (TBI)
• evaluation for toxic exposures, metabolic imbalances, sleep disorders, and chronic pain
• assessment of social determinants during clinical evaluation

This approach aligns with evidence-based suicide risk management guidelines developed jointly by VA and DoD.

Policy Recommendation #3: Improve Implementation of Patient Safety Standards

Current VA Safety Metrics:
A recent Government Accountability Office (GAO) report identified variable documentation of informed consent and other opioid risk mitigation strategies across VA facilities, underscoring the need for system-wide consistency.

Opportunity:

• Standardize and enforce documentation of informed consent, risk-benefit discussions, and medication monitoring across all high-risk classes.
• Expand clinical decision support tools in electronic health records to flag high-risk prescribing (e.g., polypharmacy with CNS depressants).
• Publicly report facility-level medication safety and outcomes to enhance accountability.

Supporting Federal Strategies and Statutes

• VA/DOD Clinical Practice Guidelines (CPGs) guide standardized suicide risk assessment and management.

Federal action plans such as the National Strategy for Suicide Prevention Federal Action Plan provide multi-agency frameworks for coordinated suicide prevention efforts.

Proposed legislation (e.g., Veteran Overmedication and Suicide Prevention Act of 2025) seeks independent review of veteran suicides to inform evidence-informed policy.

Conclusion: Toward Safer, Veteran-Centered Care

Suicide prevention for veterans requires proactive clinical safeguards, informed consent grounded in evidence, and diagnostic rigor that honors the complexity of veteran health. Policies that embed patient autonomy, transparency, and comprehensive evaluation will strengthen trust, reduce preventable harms, and save lives.

Veterans deserve a health care system that prioritizes both safety and dignity.